| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1586/14787210.5.2.255 |
| P698 | PubMed publication ID | 17402840 |
| P50 | author | Pierluigi Viale | Q113862183 |
| P2093 | author name string | Federico Pea | |
| P2860 | cites work | Antimicrobial therapy and local toxicity of intraventricular administration of vancomycin in a neonate with ventriculitis | Q48495092 |
| Successful treatment and cerebrospinal fluid penetration of oral linezolid in a patient with coagulase-negative Staphylococcus ventriculitis | Q48497879 | ||
| Risk factors for adult nosocomial meningitis after craniotomy: role of antibiotic prophylaxis | Q48684032 | ||
| Treatment of long-term intravascular catheter-related bacteraemia with antibiotic-lock therapy. | Q51148556 | ||
| In vitro evaluation of the antibiotic lock technique (ALT) for the treatment of catheter-related infections caused by staphylococci. | Q51242152 | ||
| Retrospective review of serum teicoplanin concentrations in clinical trials and their relationship to clinical outcome. | Q52569318 | ||
| Antibiotic lock-technique for the treatment of catheter-related bloodstream infections. | Q53860782 | ||
| Experience with outpatient intravenous teicoplanin therapy for chronic osteomyelitis | Q54169300 | ||
| The phannacokinetics and extravascular diffusion of teicoplanin in rabbits and comparative efficacy with vancomycin in an experimental endocarditis model | Q57203416 | ||
| Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia | Q22241905 | ||
| Biofilms: survival mechanisms of clinically relevant microorganisms | Q22299328 | ||
| Bacterial biofilms: a common cause of persistent infections | Q27861033 | ||
| Linezolid therapy of vancomycin-resistant Enterococcus faecium experimental endocarditis | Q28346136 | ||
| Pharmacokinetic and pharmacodynamic profile of linezolid in healthy volunteers and patients with Gram-positive infections | Q33347869 | ||
| Nosocomial infections in the ICU: the growing importance of antibiotic-resistant pathogens | Q33543137 | ||
| Antibiotic usage and prescribing policies in the intensive care unit | Q33901739 | ||
| Pharmacodynamics of glycopeptides in the mouse peritonitis model of Streptococcus pneumoniae or Staphylococcus aureus infection | Q33979426 | ||
| Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group | Q48029530 | ||
| Intraventricular administration of teicoplanin in shunt associated ventriculitis caused by methicillin resistant Staphylococcus aureus | Q48095686 | ||
| Cerebrospinal fluid penetration and pharmacokinetics of vancomycin administered by continuous infusion to mechanically ventilated patients in an intensive care unit | Q33979524 | ||
| Efficacy of linezolid in treatment of experimental endocarditis caused by methicillin-resistant Staphylococcus aureus | Q33982746 | ||
| Continuous versus intermittent infusion of vancomycin in severe Staphylococcal infections: prospective multicenter randomized study | Q33982863 | ||
| Pharmacodynamics of fluoroquinolones against Streptococcus pneumoniae in patients with community-acquired respiratory tract infections | Q33983119 | ||
| Clinical pharmacokinetics of teicoplanin | Q34053771 | ||
| Efficacy of telavancin (TD-6424), a rapidly bactericidal lipoglycopeptide with multiple mechanisms of action, in a murine model of pneumonia induced by methicillin-resistant Staphylococcus aureus | Q34077052 | ||
| In vivo pharmacodynamics of a new oxazolidinone (linezolid) | Q34142754 | ||
| Outcome and attributable mortality in critically Ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus. | Q34155402 | ||
| Guidelines for the management of intravascular catheter-related infections | Q34219610 | ||
| Linezolid penetration into bone and joint tissues infected with methicillin-resistant staphylococci | Q34229917 | ||
| In vivo efficacy of continuous infusion versus intermittent dosing of linezolid compared to vancomycin in a methicillin-resistant Staphylococcus aureus rabbit endocarditis model. | Q34252432 | ||
| Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections | Q34303042 | ||
| Linezolid in the treatment of Gram-positive prosthetic joint infections | Q34393206 | ||
| The VISA/GISA problem: therapeutic implications | Q34425756 | ||
| Infection control in the ICU. | Q34462731 | ||
| Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia | Q34783668 | ||
| Restrictive antibiotic policies are appropriate in intensive care units | Q35052398 | ||
| Influence of dexamethasone on efficacy of ceftriaxone and vancomycin therapy in experimental pneumococcal meningitis. | Q35118924 | ||
| Efficacy of linezolid plus rifampin in an experimental model of methicillin-susceptible Staphylococcus aureus endocarditis | Q35165783 | ||
| Effects of dosage, peak and trough concentrations in serum, protein binding, and bactericidal rate on efficacy of teicoplanin in a rabbit model of endocarditis | Q35251599 | ||
| Pharmacokinetics of intravenous linezolid in cerebrospinal fluid and plasma in neurointensive care patients with staphylococcal ventriculitis associated with external ventricular drains | Q35635671 | ||
| Clinical pharmacokinetics of quinupristin/dalfopristin | Q35684359 | ||
| Treatment of infections associated with surgical implants | Q35740678 | ||
| Analysis of vancomycin entry into pulmonary lining fluid by bronchoalveolar lavage in critically ill patients | Q35808723 | ||
| Antibiotic lock technique: a review of the literature | Q35995855 | ||
| Infections associated with medical devices: pathogenesis, management and prophylaxis | Q35999558 | ||
| Meningitis due to methicillin-resistant Staphylococcus aureus (MRSA): review of 10 cases | Q36105060 | ||
| Strategies to prevent antimicrobial resistance in the intensive care unit | Q36227201 | ||
| Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability | Q36263480 | ||
| Microbiological features of vancomycin in the 21st century: minimum inhibitory concentration creep, bactericidal/static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains | Q36328966 | ||
| The pharmacokinetic and pharmacodynamic properties of vancomycin | Q36328971 | ||
| Adaptation of methicillin-resistant Staphylococcus aureus in the face of vancomycin therapy | Q36328976 | ||
| Methicillin-Resistant S. aureus Ventilator-Associated Pneumonia: Strategies to Prevent and Treat | Q36410152 | ||
| Potential impact of vancomycin pulmonary distribution on treatment outcomes in patients with methicillin-resistant Staphylococcus aureus pneumonia | Q36428418 | ||
| The small colony variant (SCV) concept -- the role of staphylococcal SCVs in persistent infections | Q36465046 | ||
| Tolerability, pharmacokinetics, and serum bactericidal activity of intravenous dalbavancin in healthy volunteers | Q36490252 | ||
| Staphylococcus aureus isolates with reduced susceptibility to glycopeptides belong to accessory gene regulator group I or II. | Q36490837 | ||
| Antimicrobial agents in orthopaedic surgery: Prophylaxis and treatment | Q36514161 | ||
| Linezolid for the treatment of central nervous system infections in neurosurgical patients | Q39559123 | ||
| Pharmacodynamic activity and efficacy of linezolid in a rat model of pneumococcal pneumonia | Q39651829 | ||
| Comparative efficacies of ciprofloxacin, pefloxacin, and vancomycin in combination with rifampin in a rat model of methicillin-resistant Staphylococcus aureus chronic osteomyelitis | Q39816110 | ||
| Daptomycin is highly efficacious against penicillin-resistant and penicillin- and quinolone-resistant pneumococci in experimental meningitis | Q40166184 | ||
| In vitro activity of tigecycline against Staphylococcus epidermidis growing in an adherent-cell biofilm model | Q40345143 | ||
| A case of ventricular drainage infection with a rare pathogen in cerebrospinal fluid: vancomycin-resistant Enterococcus faecium. | Q40482354 | ||
| Post-neurosurgical nosocomial bacterial meningitis in adults: microbiology, clinical features, and outcomes | Q40503544 | ||
| Coagulase-negative staphylococcal meningitis in adults: clinical characteristics and therapeutic outcomes | Q40510838 | ||
| Teicoplanin in patients with acute leukaemia and febrile neutropenia: a special population benefiting from higher dosages | Q40535871 | ||
| Management of hemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solution | Q40588250 | ||
| Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. | Q41696128 | ||
| Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections | Q41762607 | ||
| Efficacy of telavancin against penicillin-resistant pneumococci and Staphylococcus aureus in a rabbit meningitis model and determination of kinetic parameters | Q41831644 | ||
| Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus | Q41865746 | ||
| Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials | Q42671287 | ||
| Cerebrospinal fluid linezolid concentrations in postneurosurgical central nervous system infections | Q42782035 | ||
| Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility | Q43433837 | ||
| Antimicrobial Treatment of Orthopedic Implant-related Infections with Rifampin Combinations | Q43463460 | ||
| Use of daptomycin to treat drug-resistant Gram-positive bone and joint infections | Q43532746 | ||
| Staphylococcus aureus meningitis in adults: a clinical comparison of infections caused by methicillin-resistant and methicillin-sensitive strains | Q43786212 | ||
| An investigation of the antimicrobial effects of linezolid on bacterial biofilms utilizing an in vitro pharmacokinetic model | Q43869462 | ||
| Methicillin-resistant Staphylococcus aureus prolongs intensive care unit stay in ventilator-associated pneumonia, despite initially appropriate antibiotic therapy | Q43905496 | ||
| Daptomycin treatment of Staphylococcus aureus experimental chronic osteomyelitis | Q43931567 | ||
| Penetration of linezolid into bone, fat, muscle and haematoma of patients undergoing routine hip replacement | Q44049240 | ||
| Time-dependent antibacterial effects of linezolid in experimental rabbit endocarditis | Q44121076 | ||
| Teicoplanin therapeutic drug monitoring in critically ill patients: a retrospective study emphasizing the importance of a loading dose | Q44374412 | ||
| Treatment of staphylococcal ventriculitis associated with external cerebrospinal fluid drains: a prospective randomized trial of intravenous compared with intraventricular vancomycin therapy | Q44439247 | ||
| Comparative efficacy of daptomycin and vancomycin in the therapy of experimental foreign body infection due to Staphylococcus aureus | Q44459200 | ||
| Clinical pharmacodynamics of linezolid in seriously ill patients treated in a compassionate use programme | Q44692777 | ||
| Clinical cure and survival in Gram-positive ventilator-associated pneumonia: retrospective analysis of two double-blind studies comparing linezolid with vancomycin | Q44721295 | ||
| Therapeutic vancomycin monitoring in children with hydrocephalus during treatment of shunt infections | Q44984629 | ||
| High dose vancomycin for osteomyelitis: continuous vs. intermittent infusion | Q44991015 | ||
| Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections | Q45127594 | ||
| Antibiotic lock with vancomycin and urokinase can successfully treat colonized central venous catheters in pediatric cancer patients | Q45189095 | ||
| Dalbavancin compared with vancomycin for prevention of Staphylococcus aureus colonization of devices in vivo | Q46393833 | ||
| Antibacterial activity of linezolid and vancomycin in an in vitro pharmacodynamic model of gram-positive catheter-related bacteraemia | Q46425775 | ||
| Comparative evaluation of tigecycline and vancomycin, with and without rifampicin, in the treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis in a rabbit model | Q46460992 | ||
| Inhibition of daptomycin by pulmonary surfactant: in vitro modeling and clinical impact | Q46494181 | ||
| Clinical experience with linezolid for the treatment of central nervous system infections | Q46548640 | ||
| Telavancin: in vitro activity against staphylococci in a biofilm model | Q46561648 | ||
| Pharmacokinetics and intrapulmonary concentrations of linezolid administered to critically ill patients with ventilator-associated pneumonia | Q46589068 | ||
| Pneumonia caused by oxacillin-resistant Staphylococcus aureus treated with glycopeptides | Q46691587 | ||
| Vancomycin versus teicoplanin in the therapy of experimental methicillin-resistant Staphylococcus aureus (MRSA) meningitis | Q46749800 | ||
| Hyperlactacidemia potentially due to linezolid overexposure in a liver transplant recipient | Q46878735 | ||
| Effects of prolonged vancomycin administration on methicillin-resistant Staphylococcus aureus (MRSA) in a patient with recurrent bacteraemia | Q46933141 | ||
| Successful treatment with linezolid and rifampicin of meningitis due to methicillin-resistant Staphylococcus epidermidis refractory to vancomycin treatment | Q46941525 | ||
| P433 | issue | 2 | |
| P921 | main subject | multiple drug resistance | Q643839 |
| pharmacodynamics | Q725307 | ||
| gram-positive bacteria | Q857288 | ||
| P304 | page(s) | 255-270 | |
| P577 | publication date | 2007-04-01 | |
| P1433 | published in | Expert Review of Anti-infective Therapy | Q15734432 |
| P1476 | title | Pharmacodynamics of antibiotics to treat multidrug-resistant Gram-positive hospital infections | |
| P478 | volume | 5 |
| Q21131083 | A new strategy to fight antimicrobial resistance: the revival of old antibiotics |
| Q37291338 | Current challenges in treating MRSA: what are the options? |
| Q51047130 | Design and prospective validation of a dosing instrument for continuous infusion of vancomycin: a within-population approach. |
| Q83390539 | Management of antimicrobial use in the intensive care unit |
| Q37190718 | Prospectively validated dosing nomograms for maximizing the pharmacodynamics of vancomycin administered by continuous infusion in critically ill patients |
| Q46728126 | Should the currently recommended twice-daily dosing still be considered the most appropriate regimen for treating MRSA ventilator-associated pneumonia with vancomycin? |
| Q34290110 | Therapeutic drug monitoring of linezolid: a retrospective monocentric analysis. |
Warning: Trying to access array offset on value of type null in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 1120 Warning: Trying to access array offset on value of type null in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 1120
Search more.